Driving Innovation in Nucleic Acid Therapeutics

by Manon Scorneaux | Apr 8, 2024

How standardized viral vector platforms can drive better service from CDMOs

by Jonathan Lecocq | Jul 12, 2022

Serum-based media concerns in viral vector manufacturing

by Jonathan Lecocq | Mar 15, 2022

Are modern scalable bioreactors the right cell culture strategy for gene and cell therapy success?

by Jonathan Lecocq | Jan 31, 2022

Gene and cell therapy manufacturing: how to design your stable cell line strategy?

by Jonathan Lecocq | Jan 5, 2022